» Articles » PMID: 22843569

Three-dimensional HepaRG Model As an Attractive Tool for Toxicity Testing

Overview
Journal Toxicol Sci
Specialty Toxicology
Date 2012 Jul 31
PMID 22843569
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

The culture of HepaRG cells as three dimensional (3D) structures in the spinner-bioreactor may represent added value as a hepatic system for toxicological purposes. The use of a cost-effective commercially available bioreactor, which is compatible with high-throughput cell analysis, constitutes an attractive approach for routine use in the drug testing industry. In order to assess specific aspects of the biotransformation capacity of the bioreactor-based HepaRG system, the induction of CYP450 enzymes (i.e., CYP1A2, 2B6, 2C9, and 3A4) and the activity of the phase II enzyme, uridine diphosphate glucuronoltransferase (UGT), were tested. The long-term functionality of the system was demonstrated by 7-week stable profiles of albumin secretion, CYP3A4 induction, and UGT activities. Immunofluorescence-based staining showed formation of tissue-like arrangements including bile canaliculi-like structures and polar distribution of transporters. The use of in silico models to analyze the in vitro data related to hepatotoxic activity of acetaminophen (APAP) demonstrated the advantage of the integration of kinetic and dynamic aspects for a better understanding of the in vitro cell behavior. The bioactivation of APAP and its related cytotoxicity was assessed in a system compatible to high-throughput screening. The approach also proved to be a good strategy to reduce the time necessary to obtain fully differentiated cell cultures. In conclusion, HepaRG cells cultured in 3D spinner-bioreactors are an attractive tool for toxicological studies, showing a liver-like performance and demonstrating a practical applicability for toxicodynamic approaches.

Citing Articles

Vitrification and rapid rewarming of precision-cut liver slices for pharmacological and biomedical research.

Ramesh S, Rao J, Namsrai B, Fisher B, Tobolt D, Megaly M bioRxiv. 2024; .

PMID: 39713303 PMC: 11661125. DOI: 10.1101/2024.12.08.627273.


Organoid as a promising tool for primary liver cancer research: a comprehensive review.

Hu X, Wei J, Liu P, Zheng Q, Zhang Y, Zhang Q Cell Biosci. 2024; 14(1):107.

PMID: 39192365 PMC: 11348559. DOI: 10.1186/s13578-024-01287-5.


Effects of total saikosaponins on CYP3A4 and CYP1A2 in HepaRG cells.

Tang Y, Li H, Tang J, Hu L, Ma F, Liu Y Exp Ther Med. 2024; 27(5):217.

PMID: 38590569 PMC: 11000459. DOI: 10.3892/etm.2024.12505.


Development of a human liver microphysiological coculture system for higher throughput chemical safety assessment.

Ip B, Madnick S, Zheng S, van Tongeren T, Hall S, Li H Toxicol Sci. 2024; 199(2):227-245.

PMID: 38335931 PMC: 11131024. DOI: 10.1093/toxsci/kfae018.


Liver three-dimensional cellular models for high-throughput chemical testing.

Yang S, Ooka M, Margolis R, Xia M Cell Rep Methods. 2023; 3(3):100432.

PMID: 37056374 PMC: 10088249. DOI: 10.1016/j.crmeth.2023.100432.